Welcome back to Under the Bioscope. In this episode, we explore the rapidly changing landscape of AI in healthcare and the new realities facing both patients and providers. With nearly 70% of adults now using AI chatbots for second opinions, often before they’ve even left the doctor's parking lot, physicians are under pressure to adapt and redefine the value they bring to the table. Joining us is Tom Blue, partner at Ovation Lab and former executive director and chief strategy officer of the American Academy of Private Physicians. Drawing on years of research into the longevity consumer, Tom shares unique insights on the evolution of patient trust, why consumers are turning to AI, and what it takes for doctors to remain a vital part of the healthcare equation in the age of powerful AI tools like Bioscope.
Timestamps:
00:00 AI's impact on longevity medicine
03:38 AI in personalized healthcare
09:56 Bias in AI models for healthcare
13:18 Trust paradox in healthcare advice
15:35 Rise and fall of DIY medicine
18:12 AI empowering patient-doctor collaboration
24:20 Advantages of Bioscope in healthcare
25:25 Enhancing health data analysis
30:55 Doctor-patient advice and AI scrutiny
32:01 AI as a healthcare partner
Bioscope AI https://bioscope.ai/
Under The Bioscope https://underthebioscope.com/
“Disclaimer: Informational only. Not medical advice. Consult your doctor for guidance.”